2019, Diabetes, Individual and Insurance

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2019

Diabetes

Individual

Insurance

Identifying and Resolving Red Flags: DEA Continues to “Run it Up the Flagpole”

FDA Law Blog

FEBRUARY 9, 2022

DEA regulations state that a pharmacist has a corresponding responsibility not to fill a prescription unless it is issued for a “legitimate medical purpose by an individual practitioner acting in the usual course of [their] professional practice.” 12, 2012) (quoting Bob’s Pharmacy & Diabetic Supplies; Revocation of Registration, 74 Fed.

IT Insurance Government Patients

Patient Groups Sue HHS, CMS for 2020 Rule Allowing the Use of Copay Accumulator Programs

FDA Law Blog

SEPTEMBER 8, 2022

As it stands, the rule allows insurers and pharmacy benefit managers (PBMs) to broadly use copay accumulator programs, which have long been criticized by patient advocacy groups as padding insurers’ pockets while leaving patients high and dry. 156.130(h) to explicitly allow insurers to broadly use copay accumulator programs.

Insurance

Insurance Patients Manufacturing Patient-Centered

Primary Care Digest

Identifying and Resolving Red Flags: DEA Continues to “Run it Up the Flagpole”

Patient Groups Sue HHS, CMS for 2020 Rule Allowing the Use of Copay Accumulator Programs

Stay Connected